Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation

Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug

(2016) Apostolos Tzikas et al.   EuroIntervention

The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation

(2014) S. L. Amorosi et al.   EUROPACE

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

(2014) B. Meier et al.   EUROPACE

Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation

(2014) Vivek Y. Reddy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

(2014) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Economic Evaluation of Percutaneous Left Atrial Appendage Occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

(2013) Sheldon M. Singh et al.   CIRCULATION

All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study

(2013) Tommy Andersson et al.   EUROPEAN HEART JOURNAL

Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients

(2013) Ariel Dogliotti et al.   HEART

Worse Stroke Outcome in Atrial Fibrillation is Explained by More Severe Hypoperfusion, Infarct Growth, and Hemorrhagic Transformation

(2013) Hans T. H. Tu et al.   International Journal of Stroke

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

(2013) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Population-Based Study of Acute- and Long-Term Care Costs after Stroke in Patients with AF

(2012) Ramon Luengo-Fernandez et al.   International Journal of Stroke

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE